Steno Diabetes Center

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial (2025) Mahaffey KW, Tuttle KR, Arici M, Baeres FM, Bakris G, Charytan DM, Cherney DZ, et al. Journal article Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6 (2025) Apperloo EM, Cherney DZ, Kuhlman AB, Mann JF, Rasmussen S, Rossing P, Tuttle KR, et al. Journal article Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials (2025) Badve SV, Bilal A, Lee MM, Sattar N, Gerstein HC, Ruff CT, McMurray JJ, et al. Journal article Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial (2024) Pratley RE, Tuttle KR, Rossing P, Rasmussen S, Perkovic V, Nielsen OW, Mann JF, et al. Journal article Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes (2024) Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JF, Bakris G, Baeres FM, et al. Journal article Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial (2024) Mann JF, Rossing P, Bakris G, Belmar N, Bosch-Traberg H, Busch R, Charytan DM, et al. Journal article From Global Domains to Physical Activity Environments: Development and Initial Validation of a Questionnaire-Based Physical Literacy Measure Designed for Large-Scale Population Surveys (2024) Elsborg P, Melby PS, Kurtzhals M, Kirkegaard H, Carl J, Rask S, Bentsen P, NIelsen G Journal article Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes (2023) Agarwal R, Ruilope LM, Ruiz-Hurtado G, Haller H, Schmieder R, Anker SD, Filippatos G, et al. Journal article Blood pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes (2022) Ruilope LM, Agarwal R, Anker SD, Filippatos G, Pitt B, Rossing P, Sarafidis P, et al. Journal article Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE) (2022) Green JB, Mottl AK, Bakris G, Heerspink HJL, Mann JFE, Mcgill JB, Nangaku M, et al. Journal article